Clinical Trial Update: Miltefosine for Children With PKDL [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for miltefosine in children with Post Kala Azar Dermal Leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-kala-azar Dermal Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Post Kala Azar Dermal Leishmaniasis | Phase 3 | Status: COMPLETED